Rajeeva V, Bhardwaj N, Batra Y K, Dhaliwal L K
Department of Anaesthesia, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Can J Anaesth. 1999 Jan;46(1):40-4. doi: 10.1007/BF03012512.
To compare the efficacy of ondansetron-dexamethasone combination with ondansetron alone for prevention of postoperative nausea and vomiting (PONV).
This double blind, randomized study was carried out in 51 female patients, aged 20-40 yr, ASA-1 physical status undergoing gynecological diagnostic laparoscopy. Group 1 (n = 26) received 4 mg ondansetron i.v. and group 2 (n = 25) received a combination of 4 mg ondansetron and 8 mg dexamethasone i.v. soon after induction of anesthesia. Postoperatively patients were assessed hourly for four hours and then at 24 hr for nausea, vomiting, pain and post anesthetic discharge score. Vomiting occurring up to two hours was considered early vomiting and from 2-24 hr as delayed vomiting.
The postoperative nausea score was lower in patients receiving a combination of ondansetron and dexamethasone (3.76) than ondansetron alone (4.38) at 0 hr (P < 0.01), 2 hr (P < 0.05) and 24 hr (P < 0.01). In group 1, 38.5% of patients had a nausea score of > or = 5 (major nausea) compared with only 12% of patients in group 2 (P < 0.025). The overall incidence of vomiting was greater in group 1 (35%) than in group 2 (8%) (P < 0.05). The combination group showed better control of delayed vomiting compared with the ondansetron group (4% vs 35%) (P < 0.01).
The combination of ondansetron and dexamethasone provides adequate control of PONV, with delayed PONV being better controlled than early PONV.
比较昂丹司琼 - 地塞米松联合用药与单用昂丹司琼预防术后恶心呕吐(PONV)的疗效。
本双盲、随机研究纳入了51例年龄在20 - 40岁、ASA - 1身体状况的女性患者,她们均接受妇科诊断性腹腔镜检查。第1组(n = 26)静脉注射4 mg昂丹司琼,第2组(n = 25)在麻醉诱导后不久静脉注射4 mg昂丹司琼与8 mg地塞米松的组合。术后每小时对患者进行4小时评估,然后在24小时时评估恶心、呕吐、疼痛及麻醉后出院评分。发生在两小时内的呕吐被视为早期呕吐,2 - 24小时内的呕吐视为延迟性呕吐。
在0小时(P < 0.01)、2小时(P < 0.05)和24小时(P < 0.01)时,接受昂丹司琼与地塞米松联合用药的患者术后恶心评分(3.76)低于单用昂丹司琼的患者(4.38)。在第1组中,38.5%的患者恶心评分为≥5分(重度恶心),而第2组中只有12%的患者如此(P < 0.025)。第1组的呕吐总发生率(35%)高于第2组(8%)(P < 0.05)。与昂丹司琼组相比,联合用药组对延迟性呕吐的控制更好(4%对35%)(P < 0.01)。
昂丹司琼与地塞米松联合用药能充分控制PONV,对延迟性PONV的控制优于早期PONV。